 BOSTON, Sept. 10, 2021 GLOBE NEWSWIRE -- Monte Rosa Therapeutics, Inc. NASDAQ: GLUE, a biotechnology company developing novel molecular glue precision medicines, today announced that it will be added to the Russell 2000 and Russell 3000 Indexes as part of second quarter initial public offering additions, effective Sept. 20, 2021. The stock will also be automatically added to the appropriate growth and value indexes. 